Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)

Completed

• Conditions: Asthma; Respiratory Symptoms

• Registration Number: NCT00882128
• Lead Sponsor: AstraZeneca

Brief Summary

To evaluate the level of control of Asthma (GINA : controlled, partially controlled, not controlled) of asthmatic patients consulting their general practitioner for a seasonal increase of respiratory symptoms (high and / or low) whether an inhaled corticotherapy is taken or not.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-04-15
• Study First Submitted QC: 2009-04-15
• Study First Posted: 2009-04-16
• Study Start: 2009-05
• Study Completion: 2009-10
• Status Verified: 2009-11
• Last Update Submitted: 2009-11-13
• Last Update Posted: 2009-11-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3300

Inclusion Criteria

• Asthmatic adults consulting for a seasonal increase of respiratory symptoms (high/low) and treated with PRN fast acting bronchodilator alone or associated with inhaled IGCS, excluding all other treatments for asthma.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate the control level of Asthma of asthmatic patients consulting their GP for a seasonal increase of respiratory symptoms (high/low) with an inhaled corticotherapy or not.	One shot (patients will only have one visit to attend - this visit will take place between May 09 and September 09)

Trial Locations

Locations (1)

Research Site; 🇫🇷 Zuydcoote, France